Enantiomeric 9-mer peptide analogs of protaetiamycine with bacterial cell selectivities and anti-inflammatory activities

Journal of Peptide Science

Volumn 17, Issue 10, 2011, Pages 675-682

  Lee, Eunjung ^a   Kim, Jin Kyoung ^a   Shin, Soyoung ^a   Jeong, Ki Woong ^a   Lee, Juneyoung ^b   Lee, Dong Gun ^b   Hwang, Jae Sam ^c   Kim, Yangmee ^a  

^a Konkuk University   (South Korea)

^b Kyungpook National University   (South Korea)

^c National Institute of Animal Science   (South Korea)

Author keywords

Anti inflammatory activity; Antimicrobial peptide; Bacterial cell selectivity; Enantiomeric analog; Protaetiamycine

Indexed keywords

9PBW2; 9PBW3; 9PBW4; DEFENSIN; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; NITRIC OXIDE; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; ENANTIOMER; GENE EXPRESSION; HEMOLYSIS; HYDROPHOBICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; CYTOKINES; DEFENSINS; INSECT PROTEINS; ISOMERISM; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; PEPTIDES;

BACTERIA (MICROORGANISMS); COLEOPTERA; HEXAPODA; MAMMALIA; PROTAETIA BREVITARSIS;

EID: 80053201947     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1387     Document Type: Article

References (35)

1. Boman HG. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 1995; 13: 61-92.
2. Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta. 1999; 1462: 11-28.
3. Hancock RE, Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 1998; 16: 82-88.
4. Hancock RE, Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 2002; 206: 143-149.
5. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
6. Andra J, Berninghausen O, Leippe M. Cecropins, antibacterial peptides from insects and mammals, are potently fungicidal against Candida albicans. Med. Microbiol. Immunol. 2001; 189: 169-173.
7. Boman HG. Antibacterial peptides: key components needed in immunity. Cell 1991; 65: 205-207.
8. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 5449-5453.
9. Otvos L, Jr. Antibacterial peptides isolated from insects. J. Pept. Sci. 2000; 6: 497-511.
10. Dimarcq JL, Bulet P, Hetru C, Hoffmann J. Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers 1998; 47: 465-477.
11. Lopez L, Morales G, Ursic R, Wolff M, Lowenberger C. Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease. Insect Biochem. Mol. Biol. 2003; 33: 439-447.
12. Bulet P, Hetru C, Dimarcq JL, Hoffmann D. Antimicrobial peptides in insects: structure and function. Dev. Comp. Immunol. 1999; 23: 329-344.
13. Hultmark D. Immune reactions in Drosophila and other insects: a model for innate immunity. Trends Genet. 1993; 9: 178-183.
14. Taylor K, Barran PE, Dorin JR. Structure-activity relationships in β-defensin peptides. Biopolymers 2008; 90: 1-7.
15. Volkoff AN, Rocher J, d'Alencon E, Bouton M, Landais I, Quesada-Moraga E, Vey A, Fournier P, Mita K, Devauchelle G. Characterization and transcriptional profiles of three Spodoptera frugiperda genes encoding cysteine-rich peptides. A new class of defensin-like genes from lepidopteran insects? Gene 2003; 319: 43-53.
16. Hwang JS, Kang BR, Kim SR, Yun EY, Park KH, Jeon JP, Nam SH, Suh HJ, Hong MY, Kim I. Molecular characterization of a defensin-like peptide from larvae of a beetle, Protaetia brevitarsis. Int. J. Indust. Entomol. 2008; 17: 131-135.
17. Shin S, Kim JK, Lee JY, Jung KW, Hwang JS, Lee J, Lee DG, Kim I, Shin SY, Kim Y. Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action. J. Pept. Sci. 2009; 15: 559-568.
18. Pliška V, Schmidt M, Fauchère JL. Partition coefficients of amino acids and hydrophobic parameters π of their side-chains as measured by thin-layer chromatography. J. Chromatogr. 1981; 216: 79-92.
19. Kim KH, Shin JH, Seo EH, Cho MC, Kang JW, Kim SH, Yu DY, Song EY, Lee HG, Sohn JH. Interleukin-32 monoclonal antibodies for immunohistochemistry, western blotting, and ELISA. J. Immunol. Methods 2008; 333: 38-50.
20. Yoshida Y, Horii K, Sakai N, Masuda H, Furuichi M, Waga I. Antibody-specific aptamer-based PCR analysis for sensitive protein detection. Anal. Bioanal. Chem. 2009; 395: 1089-1096.
21. Jeon YJ, Han SB, Ahn KS, Kim HM. Activation of NF-kappaB/Rel in angelan-stimulated macrophages. Immunopharmacology 1999; 43: 1-9.
22. Shai Y, Bach D, Yanovsky A. Channel formation properties of synthetic pardaxin and analogues. J. Biol. Chem. 1990; 265: 20202-20209.
23. Dürr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human members of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta. 2006; 1758: 1408-1425.
24. Verkleij AJ, Zwaal RF, Roelofsen B, Comfurius P, Kastelijn D, van Deenen LL. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta. 1973; 323: 178-193.
25. Mueller M, Lindner B, Kusumoto S, Fukase K, Schromm AB, Seydel U. Aggregates are the biologically active units of endotoxin. J. Biol. Chem. 2004; 279: 26307-263013.
26. Rosenfeld Y, Papo N, Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides: peptide properties and plausible modes of action. J. Biol. Chem. 2006; 281: 1636-1643.
27. Merrifield EL, Mitchell SA, Ubach J, Boman HG, Andreu D, Merrifield RB. D-enantiomers of 15-residue cecropin A-melittin hybrids. Int. J. Pept. Protein Res. 1995; 46: 214-220.
28. Wade D, Boman A, Wåhlin B, Drain CM, Andreu D, Boman HG, Merrifield RB. All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. U.S.A. 1990; 87: 4761-4765.
29. Yeaman ME, Yount NY. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 2003; 55: 27-55.
30. Brotz H, Bierbaum G, Leopold K, Reynolds PE, Sahl H-G. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis by targeting lipid II. Antimicrob. Agents Chemother. 1998; 42: 154-160.
31. Fehlbaum P, Bulet P, Chemysh S, Briand JP, Roussel JP, Letellier L, Hetru C, Hoffmann JA. Structure-activity analysis of thanatin, a 21 residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc. Natl. Acad. Sci. U.S.A. 1996; 93: 1221-1225.
32. Vunnam S, Juwadi P, Merrifield RB. Synthesis and antibacterial action of cecropin and proline-arginine-rich peptides from pig intestine. J. Peptide Res. 1997; 49: 59-66.
33. Hirakura Y, Kobayashi S, Matsuzaki K. Specific interactions of the antimicrobial peptide cyclic beta-sheet tachyplesin I with lipopolysaccharides. Biochim. Biophys. Acta. 2002; 1562: 32-36.
34. Rosenfeld Y, Sahl HG, Shai Y. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides. Biochemistry 2008; 47: 6468-6478.
35. Bland JM, De Lucca AJ, Jacks TJ, Vigo CB. All-D-cecropin B: synthesis, conformation, lipopolysaccharide binding, and antibacterial activity. Mol. Cell. Biochem. 2001; 218: 105-111.